U.S. markets closed
  • S&P 500

    4,419.15
    +18.51 (+0.42%)
     
  • Dow 30

    35,084.53
    +153.60 (+0.44%)
     
  • Nasdaq

    14,778.26
    +15.68 (+0.11%)
     
  • Russell 2000

    2,240.03
    +15.07 (+0.68%)
     
  • Crude Oil

    73.42
    +1.03 (+1.42%)
     
  • Gold

    1,832.40
    +27.80 (+1.54%)
     
  • Silver

    25.60
    +0.73 (+2.93%)
     
  • EUR/USD

    1.1893
    +0.0046 (+0.39%)
     
  • 10-Yr Bond

    1.2690
    +0.0080 (+0.63%)
     
  • GBP/USD

    1.3959
    +0.0050 (+0.36%)
     
  • USD/JPY

    109.4500
    -0.4600 (-0.42%)
     
  • BTC-USD

    39,823.98
    -175.83 (-0.44%)
     
  • CMC Crypto 200

    936.83
    +6.47 (+0.70%)
     
  • FTSE 100

    7,078.42
    +61.79 (+0.88%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

Bristol-Myers and Eisai to jointly develop, market cancer drug

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

June 17 (Reuters) - Bristol-Myers Squibb Co and Eisai Co on Thursday entered into an agreement to jointly develop and market an experimental cancer drug.

Bristol Myers will pay $650 million to Eisai and up to $2.45 billion in milestone payments. (Reporting by Amruta Khandekar; Editing by Vinay Dwivedi)